144 related articles for article (PubMed ID: 10076724)
1. Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996.
Hao D; DiFrancesco LM; Brasher PM; deMetz C; Fulton DS; DeAngelis LM; Forsyth PA
Ann Oncol; 1999 Jan; 10(1):65-70. PubMed ID: 10076724
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
3. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.
Hayakawa T; Takakura K; Abe H; Yoshimoto T; Tanaka R; Sugita K; Kikuchi H; Uozumi T; Hori T; Fukui H
J Neurooncol; 1994; 19(3):197-215. PubMed ID: 7807171
[TBL] [Abstract][Full Text] [Related]
5. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphomas--an update.
Jellinger KA; Paulus W
J Cancer Res Clin Oncol; 1992; 119(1):7-27. PubMed ID: 1400570
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): does age and histology at presentation affect outcome?
Schaller C; Kelly PJ
Zentralbl Neurochir; 1996; 57(3):156-62. PubMed ID: 8794548
[TBL] [Abstract][Full Text] [Related]
9. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
10. Management of primary central nervous system lymphoma.
El Kamar FG; Abrey LE
J Natl Compr Canc Netw; 2004 Jul; 2(4):341-9. PubMed ID: 19795597
[TBL] [Abstract][Full Text] [Related]
11. Management of immunocompetent patients with primary central nervous system lymphoma.
Chimienti E; Spina M; Vaccher E; Tirelli U
Clin Lymphoma Myeloma; 2009 Oct; 9(5):353-64. PubMed ID: 19858054
[TBL] [Abstract][Full Text] [Related]
12. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
O'Neill BP; Decker PA; Tieu C; Cerhan JR
Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
[TBL] [Abstract][Full Text] [Related]
13. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
14. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
Shin DW; Kim JH; Kim YH; Cho YH; Hong SH
J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
18. Incidence and radiographic findings of primary central nervous system lymphoma in immunocompetent patients in southern Thailand.
Rujirojindakul P; Rohitoprakarn M; Kongkabpan D; Viboonjantra P; Lekhakula A
Tumori; 2008; 94(3):304-8. PubMed ID: 18705395
[TBL] [Abstract][Full Text] [Related]
19. Primary cerebral non-Hodgkin's lymphoma (PCNSL): a review of new trends in management.
Boiardi A; Silvani A
Ital J Neurol Sci; 1997 Feb; 18(1):1-7. PubMed ID: 9115036
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
